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Archival Report
Circadian Disruptions in the Myshkin Mouse
Model of Mania Are Independent of Deﬁcits in
Suprachiasmatic Molecular Clock Function
Joseph W.S. Timothy, Natasza Klas, Harshmeena R. Sanghani, Taghreed Al-Mansouri,
Alun T.L. Hughes, Greer S. Kirshenbaum, Vincent Brienza, Mino D.C. Belle, Martin R. Ralph,
Steven J. Clapcote, and Hugh D. Piggins
ABSTRACT
BACKGROUND: Alterations in environmental light and intrinsic circadian function have strong associations with
mood disorders. The neural origins underpinning these changes remain unclear, although genetic deﬁcits in the
molecular clock regularly render mice with altered mood-associated phenotypes.
METHODS: A detailed circadian and light-associated behavioral characterization of the Na1/K1-ATPase a3 Myshkin
(Myk/1) mouse model of mania was performed. Na1/K1-ATPase a3 does not reside within the core circadian
molecular clockwork, but Myk/1 mice exhibit concomitant disruption in circadian rhythms and mood. The neural
basis of this phenotype was investigated through molecular and electrophysiological dissection of the master
circadian pacemaker, the suprachiasmatic nuclei (SCN). Light input and glutamatergic signaling to the SCN were
concomitantly assessed through behavioral assays and calcium imaging.
RESULTS: In vivo assays revealed several circadian abnormalities including lengthened period and instability of
behavioral rhythms, and elevated metabolic rate. Grossly aberrant responses to light included accentuated resetting,
accelerated re-entrainment, and an absence of locomotor suppression. Bioluminescent recording of circadian clock
protein (PERIOD2) output from ex vivo SCN revealed no deﬁcits inMyk/1molecular clock function. Optic nerve crush
rescued the circadian period of Myk/1 behavior, highlighting that afferent inputs are critical upstream mediators.
Electrophysiological and calcium imaging SCN recordings demonstrated changes in the response to glutamatergic
stimulation as well as the electrical output indicative of altered retinal input processing.
CONCLUSIONS: The Myshkin model demonstrates profound circadian and light-responsive behavioral alterations
independent of molecular clock disruption. Afferent light signaling drives behavioral changes and raises new
mechanistic implications for circadian disruption in affective disorders.
Keywords: Bipolar, Circadian, Light, Mania, Mood, Suprachiasmatic
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Bipolar disorder (BPD) is a debilitating mental health condition
that affects approximately 0.7% to 0.9% of the population of
Western societies (1). BPD is characterized by episodes of
depression, euthymia, and mania, but its etiology and neural
substrates remain poorly understood (2). Disruption of sleep
and circadian rhythms is prevalent in many mental health
diseases, including BPD, and as such, underlying circadian
systems are implicated within BPD pathophysiology (3).
Indeed, treatment of circadian rhythm abnormalities can alle-
viate symptoms of affective disorders (4,5), while circadian
clock gene polymorphisms represent risk factors across
neuropsychiatric conditions (6). Therefore, studying the circa-
dian system may provide insight into the mechanisms and root
causes of BPD.
Coordinated circadian rhythms in mammals, including
humans, originate from the master circadian clock located in
the hypothalamic suprachiasmatic nuclei (SCN) (7). SCN
neurons contain an intracellular gene–protein transcription–
translation feedback loop (TTFL) that is the molecular basis
of circadian timekeeping, and the Period1/2 (Per1/2) genes and
their protein products PERIOD1/2 (PER1/2) are key compo-
nents of this intracellular molecular clock (8). The TTFL drives
the SCN neural network to exhibit electrically excited states
during the day and relatively quiescent states at night (9). Such
variation is key for individual SCN neurons to coordinate their
internal clocks, as well as for the SCN to signal and exert
temporal control on behavior and physiology (10). Consistent
alignment of these central circadian rhythms to the external
environmental light/dark (LD) cycle is important for health and
well-being (11). Light information signaled directly from intrin-
sically photosensitive retinal ganglion cells to the SCN is crit-
ical in this process (12). This non–image-forming light input
pathway, the retinohypothalamic tract, uses the excitatory
neurotransmitter glutamate to activate SCN neurons, resetting
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the phase of the TTFL and ultimately the timing of behavioral
and brain states such as sleeping and waking (13,14). Further,
both SCN-dependent and SCN-independent actions of light
exert a powerful inﬂuence on mood pathology (15).
Intriguingly, in mice, targeted disruption of core TTFL
components alters circadian rhythms and consistently elevates
the expression of aberrant behaviors resembling those of
human affective disorders (16,17). However, because circadian
clock genes are also expressed in mood-regulating brain
centers (18,19), it is challenging to ascribe behavioral deﬁcits
directly to speciﬁc brain loci (20). Further, in human BPD, it is
unclear whether sleep and circadian disruption arise as etio-
logical drivers or as a consequence of wider pathophysiology.
To gain insight into these problems, we used the Myshkin
(Myk/1) mouse, which possesses a heterozygous inactivating
mutation in the neuron-speciﬁc Na1/K1-ATPase (NKA) a3
subunit, encoded by Atp1a3, and models the manic phase of
BPD with face, construct, and predictive validity (20,21).
Importantly, this mouse has no known TTFL deﬁcit. We report
that Myk/1 animals exhibit behavioral circadian rhythm
disruption as well as unusually heightened behavioral
responses to light and enhanced activation of SCN neurons
in vitro to a neurochemical mimic of light input. Intriguingly, we
also found that the Myk/1 SCN TTFL rhythms are intact, while
the electrophysiological output of the Myk/1 SCN neural
network was damped. Critically, we show that period-
lengthening effects on behavior of the Myshkin mutation are
ameliorated through removal of the light input pathway.
Circadian abnormalities in the Myk/1 mice arise through
alterations in light signaling and processing by the SCN. This
model provides new insights into the etiological mechanisms
of circadian disruption in animal models of affective disorders
that are independent of core circadian clock gene perturbation.
METHODS AND MATERIALS
Animal Housing and Breeding
Adult congenic Myk/1 and wild-type (1/1) animals (2–6
months of age) used in this study were bred from pairs (male
Myk/1 3 female 1/1) of animals that had been backcrossed
on to the C57BL/6NCr strain for 20 generations (20). Pilot
investigations revealed no obvious sex differences in behav-
ioral measures in either genotype, so the data from male and
female mice were combined (see also Supplemental Figure S1).
To generate mice in which the dynamic activities of the mo-
lecular clock can be monitored in tissues ex vivo, Myk/1 mice
were crossed with mPer2Luc mice bearing a knock-in PER2-
luciferase (LUC) construct (referred to here as PER2::LUC
mice) (22). Congenic1/13 PER2::LUC (1/1PER2) andMyk/1
PER2::LUC animals were generated through crosses of het-
erozygous male Myk/1 and female PER2::LUC animals. All
behavioral and in vitro studies of mice on the PER2::LUC
background were performed on ﬁlial 1 generation animals. See
Supplemental Methods for further details.
For assessment of daily rhythms in locomotor activity (with
or without a running wheel), ingestive behavior (feeding and
drinking), and metabolic activity, animals were housed singly
as previously described (23,24). Most studies were conducted
under 12-hour LD conditions; however, in some instances
animals were assessed under a day-length (16-hour light/
8-hour dark cycle) condition or in constant dark (DD) or con-
stant light (LL). These in vivo investigations were conducted
using previously established protocols (23,25); see the
Supplement for study-speciﬁc details.
For in vitro assessments of electrophysiological activity,
calcium transients, and bioluminescence rhythms in PER2::
LUC, SCN-containing brain slices were made from adult mice
using previously published protocols (26). Whole-cell current-
clamp recordings and assessment of calcium transients were
performed as previously described (9,26). Rhythms in whole
SCN slice PER2::LUC expression were assessed using lumin-
ometry, while single cells in SCN slices were visualized and
imaged using a Hamamatsu Image EM9100-13 electron-multi-
plying-CCD (Hamamatsu, Welwyn Garden City, UK) (27,28).
Data Analysis and Statistics
Unless stated otherwise, genotype comparisons were made
using two-tailed Student t test or by two-way analysis of
variance with Sidak post hoc comparisons. For within-
genotype comparisons, a one-way analysis of variance was
applied with Sidak corrections unless otherwise stated.
Nonparametric equivalents and corrections for unequal vari-
ances were utilized where appropriate and are detailed in ﬁgure
captions. The threshold for statistical signiﬁcance was set at
p , .05. See the Supplement for further details.
RESULTS
Circadian mechanisms as well as visual and non–image-
forming light pathways inﬂuence normal and pathophysiolog-
ical states including metabolism and mood behaviors (15). As
such, we sought to determine if and how murine daily and
circadian rhythms are inﬂuenced by the Myshkin mutation.
When singly housed under standard 12-hour LD conditions,
the mania phenotype of Myk/1 mice was characterized by an
inability to restrict the normal nocturnally elevated wheel-
running activity to the dark phase. Instead, Myk/1 animals
sustained vigorous activity into the ﬁrst 3 to 4 hours of the
lights-on phase (Figure 1A). Consequently, in comparison with
1/1 animals, the duration of the daily active (alpha) phase was
signiﬁcantly lengthened by w2.1 hours (Figure 1B), with the
percentage of wheel running occurring during the day elevated
by w6.9% (Figure 1C) in Myk/1 mice. Some Myk/1 animals
also showed unstable LD rhythms, with activity onsets variably
preceding the initiation of the dark phase (Figure 1A). The
effects did not rely on the provision of a running wheel,
because monitoring of general locomotor activity via infrared
detector indicated near-identical disruption in Myk/1 animals
(Supplemental Figure S4A–D). Similar effects of the Myshkin
mutation on wheel-running activity were observed in a sepa-
rate cohort of female mice (Supplemental Figure S1A–E).
In humans, extending daily exposure to light (.14 hours per
24 hours) associated with summer months can exacerbate the
symptoms of mania (29,30). When transferred into longer day
length (16 hours light/8 hours dark), Myk/1 mice exhibited
longer alpha, weaker rhythms, and w40% higher wheel
running in the light phase than 1/1 mice (Supplemental
Figure S2A–D). This reveals that the Myshkin mutation com-
promises behavioral consolidation and that increasing the
Altered Circadian Rhythms and Responses to Light in a Manic Mouse
828 Biological Psychiatry December 1, 2018; 84:827–837 www.sobp.org/journal
Biological
Psychiatry
duration of the lights-on phase overtly disrupts rhythmic con-
trol of behavior.
Circadian disruption andmental illness can alter body weight
regulation (31–33). Indeed, bipolar patients with mania can
exhibit elevated basal metabolic rate (34), so we subsequently
proﬁled metabolic activity in Myk/1 and 1/1 mice. Using indi-
rect calorimetry andmonitoring of ingestion activity for 6.5 days
under a 12-hour LD cycle,Myk/1 animals were found to exhibit
elevated basal metabolic rate, heat production, and drinking
activity (Figure 2A–C, E). The duration of their elevated meta-
bolic activity was sustained into the lights-on phase (Figure 2A,
F); ingestive behavior was increased during the lights-on phase
but was reduced over 24 hours (Figure 2D, G).
In nocturnal rodents, light exposure typically suppresses
locomotor behaviors (negative masking), but when exposed to
1-hour or 8-hour pulses of light during the night, Myk/1 mice
maintained activity or increased wheel-running behavior during
the pulses, while 1/1 animals reduced locomotor activity
(Figure 1D–F). Further, when released into an illuminated
(w1.5 mW/cm2) open-ﬁeld test arena for 15 minutes during the
early night (Zeitgeber time 15–18 [ZT15–18]), hyperlocomotor
activity (as assessed by distance traversed) was marked in
Myk/1 but not in 1/1 mice (Supplemental Figure S3). There-
fore, unlike other nocturnal rodents such as the Syrian hamster
(35) as well as mice with TTFL mutations (36), Myk/1 mice do
not exhibit pronounced negative masking, an effect overtly
manifested in wheel running during the day.
BecauseMyk/1 mice exhibited disrupted rhythms under LD
conditions, their intrinsic circadian rhythms in wheel-running
behavior were initially assessed over 14 days in the absence
of light (DD). Consistent with a previous report (20), behavioral
rhythms ofMyk/1mice differed signiﬁcantly from those of1/1
animals. Myk/1 mice displayed a lengthened period
(Figure 3A–D;w24.2 hours vs.w23.5 hours) and an unusually
elongated active phase (Figure 3E: alpha; w19.0 hours vs.
w13.1 hours), while the amplitude, or strength (percent vari-
ance as measured by chi-square periodogram), of their
behavioral rhythms was also markedly reduced (Figure 3F). In a
separate all-female cohort,Myk/1 animals also showed similar
changes in circadian rhythms of wheel running in DD
(Supplemental Figure S1A, B, F–H). These effects of the
Myshkin mutation were not dependent on the provision of a
running wheel (37,38), as similar changes in general locomotor
activity rhythms were exhibited by animals monitored with a
passive infrared system without a functioning running wheel
(Supplemental Figure S4A, B, E, F).
When assessed for an additional 14 to 21 days in DD, all
1/1 animals sustained rhythmic wheel-running activity,
whereas that of some Myk/1 mice (n = 3 of 38; 8%) weakened
and they became circadianly arrhythmic (Figure 3C). Addi-
tionally, some Myk/1 animals (but no 1/1 mice) exhibited
gradual unusual changes in free-running period (n = 8 of 38;
21%) either spontaneously or following transfer to a clean cage
(Supplemental Figure S5A–C). Because rhythm amplitude and
free-running stability are metrics for the output strength of the
circadian system, this indicates that Myk/1 animals possess
diminished and unstable central circadian regulation of
behavior and physiology.
Figure 1. The Myshkin mutation alters the
suppression of wheel-running behavior by light.
(A) Example double-plotted actograms from wild-
type (1/1) (n = 37) and Myk/1 (n = 38) mice main-
tained under 12-hour light/dark conditions. Red
boxes indicate typical region when “tails” in Myk/1
light-phase activity occur. Gray-shaded areas of
actograms delineate lights off (dark). Zeitgeber time
0 (ZT0) = lights on; ZT12 = lights off. (B) Alpha
duration under these 12-hour light/dark conditions is
elongated in Myk/1 animals (1/1: 11.95 6 0.12
hours, Myk/1: 14.07 6 0.32 hours; p , .0001).
(C) Percentage of total daily activity in the lights-on
phase is increased by the Myshkin mutation (1/1:
5.8 6 1.2%, Myk/1: 12.7 6 2.7%; p = .043).
(D) Example single-plotted actograms showing the
presence (1/1 mice) and absence (Myk/1 animals)
of negative masking responses to 1-hour or 8-hour
light pulses given during the lights-off phase.
(E) Wheel revolutions per hour exhibited during
these 1-hour or 8-hour light pulses are increased by
the Myshkin mutation (1/1: 45 6 13 revolutions/
hour21 (rev h21),Myk/1: 239 6 62 rev h21; p = .005).
(F) Locomotor activity during light pulse (running
wheel revolutions) normalized to each animal’s daily
mean is higher in Myk/1 mice (1/1: 0.13 6 0.05
relative wheel revolutions, Myk/1: 0.52 6 0.12 rela-
tive wheel revolutions; p = .002). Data are plotted as
mean 6 SEM. *p , .05; ** p , .01; ***p , .001.
Altered Circadian Rhythms and Responses to Light in a Manic Mouse
Biological Psychiatry December 1, 2018; 84:827–837 www.sobp.org/journal 829
Biological
Psychiatry
For rodents in DD, light exposure during the night shifts
subsequent onsets of activity; early night exposure (circadian
time 14–18 [CT14–18]) delays circadian rhythms, while light
given later in the night (CT20–24) advances rhythm onsets (39),
so we next sought to determine if the Myshkin mutation
affected photic resetting of the circadian system. Mice were
released from 12-hour LD conditions into DD and, after 14
days, were exposed to a 1-hour light pulse either late
(CT20–21; Figure 4A, B) or early (CT14–15; Figure 4C, D)
in their active subjective night (an Aschoff type I protocol).
The subsequent phase of the onset of their wheel-running
rhythms was then measured (23). When exposed to light
pulses at CT14, Myk/1 mice showed much larger phase
delays than 1/1 mice (w22.32 hours vs. w21.6 hours,
p = .008; Figure 4C–E). Light pulse treatment at CT20 evoked
phase delays inMyk/1 activity that were unusual, as they were
of the opposite direction to typical advances elicited at this
time in 1/1 mice (w21.3 hours vs. 10.5 hours, p # .02;
Figure 2. Altered metabolic rhythms in Myk/1 mice. (A) Smoothed traces of wild-type (1/1) mice (blue; n = 10) and Myk/1 mice (red; n = 12) maximal
oxygen consumption (Vol O2) over 6.5 days. Gray-shaded columns delineate lights off (dark). (B)Mean Vol O2 consumption is elevated inMyk/1 animals (1/1:
2.91 6 0.14 L/kg/hour, Myk/1: 3.86 6 0.13 L/kg/hour; p , .0001). (C) Mean hourly heat production is elevated in the Myk/1 mice (1/1: 0.0148 6
0.0007 kcal/g/hour, Myk/1: 0.196 6 0.0008 kcal/g/hour; p = .0003). (D) Altered ingestive behaviors in Myk/1 animals. Mean hourly food hopper visits were
reduced by the Myshkin mutation (1/1: 92.6 6 4.3 visits, Myk/1: 64.6 6 5.1 visits; p = .0005). (E) Mean hourly visits to drinking spout were increased by
the Myshkin mutation (1/1: 90.0 6 13.2 visits/hour, Myk/1: 172.6 6 31.7 visits/hour; p = .03). (F) Altered duration of daily peak (1/1: 10.37 6 0.23 hours,
Myk/1: 13 6 0.75 hours; p = .003) and nadir (1/1: 8.59 6 0.30 hours, Myk/1: 5.05 6 0.75 hours; p = .0004) in Vol O2 activity. (G) The Myshkin mutation
increases percentage of daily feeding occurring during the lights-on phase (1/1: 25.0 6 1.9%, Myk/1: 36.3 6 1.3%; p , .0001). Data in panels (C–G) are
plotted as mean 6 SEM. *p , .05, **p , .01, ***p , .001. LD, light/dark.
Figure 3. Altered free-running rhythms in Myk/1
mice. (A–C) Example double-plotted actograms of
wild-type (1/1) and Myk/1 animals released into
constant dark (indicated by gray shading) following
entrainment to 12-hour light/dark cycle. Most Myk/1
mice maintained rhythms in constant dark (B), but
exceptionally, some (C) became arrhythmic. Red
rectangles delineate timing of typical elevated wheel
running in the Myk/1 mice. (D) The Myshkin muta-
tion lengthened free-running period (1/1: 23.72 6
0.03 hours, Myk/1: 24.22 6 0.02 hours; p , .0001)
and (E) alpha duration (1/1: 13.14 6 0.26 hours,
Myk/1: 18.99 6 0.37 hours; p , .0001). (F) The
amplitude of daily wheel-running rhythms is reduced
by theMyshkinmutation (as measured by chi-square
periodogram; 1/1: 43.8 6 3.1% variance, Myk/1:
27.7 6 2.4% variance; p = .001). Data in panels
(D–F) are graphed as scatter plots with mean 6
SEM. ***p , .001.
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Figure 4A, B, E). No genotype differences were found with a
light pulse given near the subjective night-day transition (CT23;
Figure 4E). This experiment was repeated with 1-hour light
pulses given within 48 hours following release from 12-hour LD
into DD (an Aschoff type II protocol) with similarly altered
resetting patterns observed (Figure 4F–H). This indicates that
the altered phase shifts to light observed inMyk/1mice do not
emerge as a consequence of long-term adaptation to DD.
Thus, the Myshkin mutation both accentuates and alters the
temporal pattern of the resetting effects of light on murine
rhythms in behavior.
We next assessed if the Myshkin mutation inﬂuenced how
mice respond to simulated jetlag. Jetlag and other external
disruptors to normal activity rhythms are associated with the
presentation of episodes in BPD, and therefore sensitivity to
external perturbation represents an important measure (40,41).
In response to the 8-hour advance (Figure 5A–D) or delay
(Supplemental Figure S5D, E) of the LD cycle, Myk/1 mice
rapidly altered their daily pattern of wheel running within 2 to 4
days, whereas 1/1 animals took 6 to 8 days to resynchronize.
Comparable rapid resynchronization to an 8-hour advance in
the LD cycle was also observed in a separate cohort of female
Myk/1 mice (Supplemental Figure S1A, B, I, J). To directly test
if the Myshkin mutation enhances the photic resetting capa-
bilities of the neural circadian system, animals were next
subjected to a transient 7-hour advance of the LD cycle for
2 days then released into free-running DD conditions
(Figure 5E, F). Again,Myk/1mice demonstrated unusually large
advances in the new phase of their activity onsets, and on the
ﬁrst day in DD these were of much greater magnitude (w8.3
hours vs.w2.2 hours) than were those shown by 1/1 animals
(Figure 5G, H). This ﬁnding indicates that mechanisms that
normally brake the circadian system to prevent extraordinarily
large resetting are dysfunctional in Myk/1 animals (42,43).
In rodents, exposure to LL suppresses wheel-running
behavior and lengthens the period of circadian rhythms (24,44),
so we next assessed how Myk/1 mice adapt to LL. Consistent
with previous research, all 81/1 animals showed a suppression
ofwheel running inLL (reducedbyw90%fromLD) andexhibited
free-running rhythms with a period ofw25 hours (Supplemental
Figure S1A, B, K). Myk/1 animals also showed longer period
rhythms in LL (w25 hours), but most (5 of 7) exhibited markedly
elevated wheel running in LL (w403% increase from LD).
Therefore, while the period-lengthening effects of LL are
observed inMyk/1 animals, some individuals sustain increased
rather than decreased locomotor activity.
The NKA a3 pump is localized to several central nervous
system structures, including retinal ganglion cells whose axons
project along the optic nerve (45,46), so we next investigated if
retinal input to the SCN contributed to the altered circadian
rhythms of Myk/1 mice. To do so, mice free running in DD
either underwent a sham surgical procedure or had their optic
nerves crushed (see the Supplement for procedural details).
Optic nerve crush in Myk/1 mice markedly shortened their
circadian period by w20.7 hours to w23.6 hours, while 1/1
animals showed no obvious change in circadian period
(Figure 6A–C). Similarly,Myk/1mice undergoing sham surgical
procedure showed no change in free-running period
(Figure 6C). This indicates that aberrant intrinsic activity of the
light input pathway to the SCN contributes to the period-
lengthening effect of the Myshkin mutation.
Glutamate is the main neurochemical of the retinal input
pathway to the SCN, and stimulation of the alpha-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)–type
Figure 4. Enhanced circadian resetting responses
to light in Myk/1 mice. (A, B) Example double-
plotted actograms showing resetting effects of a
1-hour light pulse (Aschoff type I protocol) given
under constant dark conditions to wild-type (1/1)
and Myk/1 animals (white boxes indicate light pulse)
during the late subjective night (circadian time [CT]
20). Note the opposing direction (delay) of the phase
shift in Myk/1 activity onset compared with the
advance in activity onset of the 1/1 animal. (C, D)
Example double-plotted actograms illustrating the
shifting effects of a 1-hour light pulse (Aschoff type I
protocol) given early in the subjective night (CT14) on
the free-running rhythms of 1/1 and Myk/1 ani-
mals. Myk/1 animals exhibited larger phase delays
at CT14. (E) Individual responses to 1-hour light
pulses given under Aschoff type I protocol (CT14,
1/1: 21.6 6 0.1 hours, Myk/1: 22.3 6 0.1 hours,
p = .008; CT20, 1/1: 0.5 6 0.1 hours, Myk/1: 21.3
6 0.4 hours, p = .002; CT23, 1/1: 0.6 6 0.1 hours,
Myk/1: 0.2 6 0.2 hours, p = .14). (F, G) Double-
plotted actograms showing the phase resetting re-
sponses of 1/1 and Myk/1 mice to 1-hour light
pulse given early in the subjective night (CT14)
following transfer from light/dark to constant dark
conditions (Aschoff type II protocol). Animals were
exposed to a 1-hour light pulse within 48 hours
following release into constant dark. (H) Individual
responses to 1-hour light pulses presented under Aschoff type II protocol (CT14,1/1:21.16 0.1 hours,Myk/1:21.86 0.2 hours, p = .03; CT20,1/1: 0.766
0.08 hours, Myk/1: 20.48 6 0.18 hours, p = .0001). Panels (E) and (H) are graphed as scatter plots with mean 6 SEM. *p , .05, **p , .01, ***p , .001.
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glutamate receptors excites SCN neurons, elevates intracel-
lular Ca21, and can shift the phase of behavioral rhythms
(47,48). To determine if acute responses of SCN neurons to
glutamate were altered by theMyshkin mutation, the actions of
AMPA (5–20 mM) on intracellular Ca21 were assessed in 1/1
and Myk/1 hypothalamic SCN brain slices. Neurons were
loaded with the ﬂuorescent calcium indicator dye Fura-2-
acetoxymethyl ester to enable recording of somatic intracel-
lular Ca21 changes across populations of single SCN cells
(Supplemental Figure S6A).
During the day (ZT4–10), AMPA treatments evoked changes
in intracellular Ca21 of similar magnitude and duration in
both genotypes (Supplemental Figure S6B, C). However, with
applications made during the night (ZT14–18), AMPA elicited
increases in intracellular Ca21 that were signiﬁcantly larger
in Myk/1 neurons compared with 1/1 SCN neurons
(Figure 6D, E). At this time, response magnitude was dose
dependent (5 and 10 mM), with baseline recovery from the 10-
mM application taking signiﬁcantly longer in the Myk/1 SCN
neurons (Figure 6F). Such changes in AMPA responses indi-
cate that, in addition to altering retinohypothalamic tract
activity, the Myshkin mutation enhances the processing of a
neurochemical mimic of this light input pathway to the SCN.
To gain further insight into the etiology of circadian distur-
bances arising from the Myshkin mutation, we next investi-
gated the anatomy and TTFL molecular pacemaking of the
Myk/1 SCN. The SCN exhibit characteristic, spatially distinct
neuropeptide topography. Immunohistochemical staining for
major SCN neuropeptides, vasoactive intestinal polypeptide
and arginine vasopressin, showed no overt genotype differ-
ences in the pattern of expression (Supplemental Figure S7).
Molecular clock activity was then tracked through expression
Figure 5. Rapid adaptation to simulated jetlag in Myk/1 mice. (A, B) Double-plotted actograms of mice exposed to simulated jetlag protocol; here the light/
dark (LD) cycle was advanced by 8 hours. Red boxes indicate the time point at which the animals were designated as having re-entrained to the new LD cycle.
Gray-shaded areas in actograms and in panels (C) and (G) delineate lights off (dark). (C) Myk/1 mice readjust their daily onset in wheel-running activity to the
new LD phase more rapidly than do wild-type (1/1) mice. Note the large readjustment in the onset of daily wheel running observed in theMyk/1mice on day 1
following the advance in the LD cycle. (D)Myk/1mice take fewer days to re-entrain their wheel-running activity to the new LD cycle than do1/1 animals (1/1:
6.5 6 0.7 days vs. Myk/1: 3.6 6 0.6 days; p = .006). (E, F) Double-plotted example actograms of 1/1 and Myk/1 animals responding to transient jetlag. To
validate resetting of the circadian system to simulated jetlag seen in panels (A, B), mice were exposed to a 7-hour advance of the 12-hour LD cycle for 48 hours
and then released into constant dark. Myk/1 animals show a large magnitude advance in the timing of their wheel-running activity. (G) The larger readjustment
of the onset in daily wheel running ofMyk/1mice is sustained in constant dark, indicating that the circadian system of these animals has reset to a much larger
extent than 1/1 mice. (H) Mean phase shift on ﬁrst 24 hours in constant dark is signiﬁcantly larger in Myk/1 mice (1/1: 2.2 6 0.5 hours, Myk/1: 8.3 6 0.8
hours; p , .0001). Data in panels (C, D, G, H) plotted as mean 6 SEM. **p , .01, ***p , .001.
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of the circadian clock protein PER2 via PER2::LUC expres-
sion in SCN explants (Supplemental Figure S8). The charac-
teristics of circadian rhythms in wheel running seen in Myk/1
mice (increased circadian period and alpha) were maintained
in Myk/1PER2::LUC mice (Supplemental Figure S8A–E).
Surprisingly, in SCN explants cultured ex vivo, no overt
genotype differences were found in period or amplitude of
whole-tissue PER2::LUC expression (Figure 7A–C). Similarly,
in SCN explants imaged at single-cell resolution, neither the
period nor the damping rate of single-cell rhythms nor the
intercellular synchrony within SCN slices differed between
the genotypes (Figure 7D–F). The persistence of 1/1PER2-
like rhythms ex vivo indicates that, in isolation, the Myk/1
SCN is a stable pacemaker. Together with the ﬁndings from
the optic nerve crush experiment, this reinforces the idea
that, in vivo, afferent signals such as those coming from the
eye act to diminish the Myk/1 SCN’s control of physiology
and behavior.
Neurons of the SCN control behavior and physiology in part
by varying their spontaneous ﬁring rate (SFR), with higher
frequency discharge during the day than at night (49). Because
neurophysiological studies suggest that the NKA pump in-
ﬂuences SCN neurons (50), and because NKA a3 subunits
affect membrane excitability (51,52), we next made whole-cell
electrophysiological recordings and assessed the electrical
activity of 1/1 and Myk/1 SCN neurons maintained in brain
slices. SCN neurons exhibit distinct electrophysiological states
(9,53) and these were evident in both 1/1 and Myk/1 SCN
recordings, but no genotype differences were detected in most
passive properties of these neurons (Supplemental Table S1).
However, comparison of the SFR of Myk/1 and 1/1 SCN
neurons based on the time of recording indicated clear
genotype-related differences. Unexpectedly, the mean SFR of
Myk/1 SCN neurons did not differ from day to night re-
cordings, whereas 1/1 SCN neurons had signiﬁcantly higher
SFR during the day as compared with the night (Figure 7G).
Day/night variation in SFR is a key characteristic of the SCN
network both in vitro and in vivo, and because the TTFL
appears to be intact in theMyk/1 SCN, this damping inMyk/1
SCN neuronal activity most likely arises from exposure to
altered photic afferent signals.
DISCUSSION
Here we have demonstrated that, in addition to increases in
the period and active phase duration of circadian rhythms in
behavior, the Myk/1 mouse exhibits instability in behavioral
rhythms and unusually heightened circadian resetting/
re-entrainment responses to light. Other mouse models
expressing mania-like states, including ClockD19, Reverba–/–,
and DAT–/– mice, also show heightened phase-shifting re-
sponses to light (54–56). Interestingly, in patients with mania,
locomotor rhythms may also weaken with increasing severity
of manic symptoms (57), and sensitivity to both white and blue
light is heightened during manic episodes (58–60). Similar to
bipolar patients (61,62), Myk/1 mice exhibit both altered sleep
patterns (20) and circadian rhythm disturbance as well as
elevated metabolic activity (34). Notably, the nocturnally
elevated metabolic rate and locomotor activity of Myk/1 mice
were not suppressed by light, indicating the absence of
negative masking. Consistent with this, Myk/1 mice did not
behaviorally adjust to a long day length, and in LL they
increased wheel running, whereas1/1mice markedly reduced
it. Indeed, even in the absence of light, alterations in retinal
afferents were sufﬁcient to drive circadian behavioral disrup-
tion, because removal of afferent photic input to the SCN
in vivo restored the circadian period of behavioral rhythms.
Further, when cultured in vitro and assessed in isolation from
retinal inputs,Myk/1 single-cell PER2 rhythms and whole-SCN
explants behaved as stable pacemakers, comparable to 1/1
SCN tissue. This indicates that the SCN molecular clock is
largely intact in this mouse model of mania, a ﬁnding
Figure 6. Altered retinal signals and excitatory
processing within the suprachiasmatic nuclei (SCN)
underlie Myk/1 circadian behavioral phenotypes. (A,
B) Double-plotted wheel-running actograms illus-
trating the effects of optic nerve crush (ONC) in wild-
type (1/1) and Myk/1 animals maintained in con-
stant dark conditions. Red arrows delineate the day
of ONC. Red lines are ﬁtted through activity onsets
pre- and postsurgical intervention. The free-running
period of Myk/1 mice was restored by ONC but
not sham procedure. (C) Mean period of cohorts
undergoing ONC or sham procedure (1/1 ONC
n = 6: w20.1 hours, p = .13; Myk/1 ONC
n = 6: 20.75 hours, p = .025; Myk/1 sham n = 4:
w20.1 hours, p = .12). (D) Example responses of
single SCN neurons loaded with Fura-2 to alpha-
amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid (AMPA) (5 and 10 mM) tested during subjective
night (1/1: n = 88, Myk/1: n = 148). (E)When tested
during the subjective night (Zeitgeber time 14–18
[ZT14–18]), Myk/1 SCN neurons exhibited larger AMPA-evoked cellular increases in intracellular Ca21 than did 1/1 SCN neurons (two-way analysis of
variance: interaction p , .0001; 1/1 5 mM: 0.16 6 0.01 arbitrary units (A.U.), Myk/1 5 mM: 0.22 6 0.01 A.U., Sidak p = .0029; 1/1 10 mM: 0.22 6 0.01 A.U.,
Myk/1 10 mM: 0.356 0.01, p, .0001). (F) During subjective night (ZT14–18), the washout duration following AMPA treatment (10 mM) was longer in theMyk/1
neurons compared with 1/1 SCN neurons (1/1 5 mM: 121 6 4 seconds, Myk/1 5 mM: 121 6 4 seconds, p = .99; 1/1 10 mM: 172 6 4 seconds, Myk/1
10 mM: 209 6 8 seconds, p = .0007). Data in panels (C, E, F) are plotted as mean 6 SEM. *p , .05, **p , .01, ***p , .001.
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concordant with the observation that the molecular clock is
also intact in ﬁbroblasts from patients with BPD (63). However,
Myk/1 SCN slices lacked day/night variation in neuronal ﬁring
rate. Importantly, the low amplitude, long period behavioral
rhythms, and damped SCN electrical activity of Myk/1 mice
resemble similar measures made from 1/1 mice exposed to
long day lengths or LL (44,64–66). These ﬁndings reveal an
important role for light inputs to the SCN in this mouse model
of mania.
NKA a3 is localized to central and peripheral neurons,
including retinal ganglion cells (46,67), and glutamate is the
main neurotransmitter of image- and non–image-forming
pathways from the eye (12,49). Both SCN and extra-SCN
sites are implicated in masking effects of light (68,69) and
the absence of negative masking in Myk/1 mice presumably
arises as a consequence of altered glutamatergic signaling at
these sites. Glutamatergic synapses are linked with mood
disorders (70), and it is suggested that measures of glutamate
in the brain vary in BPD, becoming elevated during mania and
reduced in episodes of depression (71). Further, mood stabi-
lizers used to treat BPD, such as lithium and valproate, act to
restore glutamate levels (72,73) and can reduce sensitivity to
light and directly alter SCN function (74,75). Interestingly,
colocalization and functional coupling between NKA a3 and
glutamate transporters has been demonstrated in rat brain,
with a3 having similar neuronal localization to excitatory amino
acid transporter 2/glutamate transporter 1, the most abundant
subtype of glutamate transporter in the central nervous system
(76). Previously, Kirshenbaum et al. (20) found that the duration
of glutamate-evoked [Ca21]i transients was prolonged in
cultured cortical neurons from Myk/1 mice (20), raising the
possibility that this mutation alters glutamatergic signaling in
other brain pathways. Because metabolic rate is elevated
in Myk/1 mice, it is plausible that the Myshkin mutation
inﬂuences energy balance centers in the mediobasal hypo-
thalamus (77).
In high-ﬁring hippocampal and cerebellar neurons, loss or
reduction of NKA a3 is associated with neuronal hyper-
excitablity (20,51,78,79). Atp1a3 is expressed in the SCN (80),
but Myk/1 SCN neurons that have a reduction in functional
NKA a3 show damped daytime ﬁring rate. To discharge action
potentials, high-ﬁring cells can require considerable adenosine
triphosphate, and a likely consequence of a reduction in NKA
pump activity is ionic imbalance and chronic depolarization
(81). Because individual SCN neurons are comparatively low
ﬁring (typically ,5 Hz), this suggests that their adenosine
triphosphate requirements are low, such that a reduction in
NKA a3 activity does not drive the cell into a chronic
Figure 7. TheMyshkinmutation does not affect bioluminescent rhythms of PER2::LUC in whole suprachiasmatic nuclei (SCN) brain slices or single cells, but
rather damps electrophysiological activity. (A) Example luminometric recordings of rhythms of PER2::LUC output of whole SCN tissue explants from
1/1PER2::LUC (1/1PER2) and Myk/1PER2::LUC (Myk/1PER2). (B) No genotype differences were detected in the period of PER2::LUC oscillations
(1/1PER2: 24.73 6 0.05 hours, Myk/1PER2: 24.82 6 0.09 hours; p = .39). (C) Peak amplitude of PER2::LUC rhythms across the ﬁrst 5 days (24-hour cy-
cles) in culture did not differ between the genotypes (two-way analysis of variance: genotype p = .78; interaction p = .13). (D) Example of single-cell imaging
from 1/1PER2 (n = 4) and Myk/1PER2 (n = 4) explants at two time points over initial 24 hours ex vivo. (E) The period of single-cell rhythms did not differ
between the genotypes (1/1PER2: n = 140, 23.966 0.06 hours;Myk/1PER2: n = 132, 23.966 0.07 hours; p = .99). (F) The synchrony (R) between single cells
in the SCN slices did not differ between the genotypes at any of the 5 days (5 3 24-hour cycles) ex vivo (two-way analysis of variance: genotype p = .70).
(G) Mean spontaneous ﬁring rate (SFR) from whole-cell current-clamp recordings made over a 24-hour cycle. Day/night variation in SFR is seen across 1/1
SCN neurons but not Myk/1 SCN neurons (two-way analysis of variance: time p = .0079; 1/1 day: 2.0 6 0.2 Hz, 1/1 night: 1.2 6 0.2 Hz, p = .0009; Myk/1
day: 1.6 6 0.2 Hz, Myk/1 night: 1.4 6 0.2 Hz; p = .31). Data in panel (E) graphed as scatter plot with mean 6 SEM. Data in panels (B, C, F, G) plotted as
mean 6 SEM. ***p , .001. A.U., arbitrary units; CT, circadian time.
Altered Circadian Rhythms and Responses to Light in a Manic Mouse
834 Biological Psychiatry December 1, 2018; 84:827–837 www.sobp.org/journal
Biological
Psychiatry
depolarized state. Indeed, because some classes of intrinsi-
cally photosensitive retinal ganglion cells can spontaneously
ﬁre at high frequencies (70–90 Hz) (82), it is probable that they
are more readily hyperexcited through the reduction in NKA a3
activity, as is evidenced by the associated changes in retinal
input to the SCN in Myk/1 animals.
NKA a subunits (a1–a3) are associated with BPD, although
subunit-speciﬁc roles in pathology remain to be deﬁned
(20,83,84). A heterozygous missense mutation (V129M) in
NKA a3 was identiﬁed in a 9-year-old boy with DSM-5
schizophrenia and a clinical presentation including mood
swings (85). Multiple Atp1a3-speciﬁc mutant mouse models
exhibit variable presentations of neurological deﬁcits (86,87),
but one key commonality is that all show heightened psy-
chomotor states. Missense mutations in NKA a3 have been
identiﬁed in other neurological conditions including rapid-
onset dystonia parkinsonism, alternating hemiplegia of
childhood (AHC), and CAPOS (cerebellar ataxia, areﬂexia, pes
cavus, optic atrophy, and sensorineural hearing loss) syn-
drome (88,89). Patients with rapid-onset dystonia parkin-
sonism show greater incidence of mood and psychotic
symptoms than control family members (90). AHC patients
are easily aroused and prone to behavioral and psychiatric
symptoms, such as impulsivity, lack of attention control, and
episodes of hyperactivity (H. Rosewich, M.D., personal
communication, July 6, 2016). Clinical presentation of AHC is
sensitive to changes in lighting and sleep induction. Indeed,
acute presentation of AHC symptoms such as hemiplegic
attacks can be triggered by stimulation of the optic system
(H. Rosewich, personal communication) and attenuated
through occlusion of the eyes (91). In addition to circadian-
associated behaviors, therefore, our ﬁndings support a
wider role of light and retinal signaling in the pathology of
ATP1A3-related disorders. As the activity of NKA a3 was
recently found to be impaired by its aberrant association with
misfolded and aggregated amyloid-b in Alzheimer’s disease
(92) and a-synuclein in Parkinson’s disease (93), NKA a3
dysfunction may also contribute to the circadian sleep dis-
turbances in these common age-related neurodegenerative
conditions (94–96).
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